Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Nanovibronix, Inc. (NAOV : NSDQ)
 
 • Company Description   
NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.

Number of Employees: 31

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.65 Daily Weekly Monthly
20 Day Moving Average: 38,111 shares
Shares Outstanding: 1.01 (millions)
Market Capitalization: $4.70 (millions)
Beta: 2.16
52 Week High: $94.71
52 Week Low: $4.43
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -26.42% -28.35%
12 Week -20.65% -23.94%
Year To Date -92.84% -93.74%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
969 PRUITT AVE
-
TYLER,TX 77569
USA		 ph: 914-233-3004
fax: 914-376-6111		 ir@taosynergies.com http://www.nanovibronix.com
 
 • General Corporate Information   
Officers
Brian Murphy - Chief Executive Officer and Director
Christopher Fashek - Chairman of the Board
Stephen Brown - Chief Financial Officer
Martin Goldstein - Director
Doron Besser - Director

Peer Information
Nanovibronix, Inc. (ABMD)
Nanovibronix, Inc. (DMDS)
Nanovibronix, Inc. (CPWY.)
Nanovibronix, Inc. (EQUR)
Nanovibronix, Inc. (ECIA)
Nanovibronix, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 63008J884
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/13/25
Share - Related Items
Shares Outstanding: 1.01
Most Recent Split Date: 8.00 (0.10:1)
Beta: 2.16
Market Capitalization: $4.70 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.09
Price/Cash Flow: -
Price / Sales: 2.01
EPS Growth
vs. Year Ago Period: 96.25%
vs. Previous Quarter: 97.41%
Sales Growth
vs. Year Ago Period: -39.53%
vs. Previous Quarter: -51.80%
ROE
09/30/25 - -
06/30/25 - -45.24
03/31/25 - -54.73
ROA
09/30/25 - -
06/30/25 - -34.24
03/31/25 - -38.63
Current Ratio
09/30/25 - -
06/30/25 - 1.05
03/31/25 - 0.47
Quick Ratio
09/30/25 - -
06/30/25 - 0.72
03/31/25 - 0.22
Operating Margin
09/30/25 - -
06/30/25 - -380.29
03/31/25 - -210.82
Net Margin
09/30/25 - -
06/30/25 - -380.29
03/31/25 - -210.82
Pre-Tax Margin
09/30/25 - -
06/30/25 - -376.66
03/31/25 - -209.80
Book Value
09/30/25 - -
06/30/25 - 51.41
03/31/25 - 432.15
Inventory Turnover
09/30/25 - -
06/30/25 - 0.73
03/31/25 - 0.65
Debt-to-Equity
09/30/25 - -
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - -
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©